These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1180 related items for PubMed ID: 16424649

  • 21. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD, Goldsmith G.
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [Abstract] [Full Text] [Related]

  • 22. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
    Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, Faranoush M, Ehsani MA.
    Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
    [Abstract] [Full Text] [Related]

  • 23. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E, Vijatov G.
    Med Pregl; 1998 Dec; 51(3-4):127-34. PubMed ID: 9611955
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia.
    Naithani R, Kumar R, Mahapatra M, Tyagi S, Saxena R.
    Platelets; 2009 Nov; 20(7):525-7. PubMed ID: 19852693
    [Abstract] [Full Text] [Related]

  • 25. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS, Carcao M.
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [Abstract] [Full Text] [Related]

  • 26. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM, Shalev H, Kapelushnik J.
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [Abstract] [Full Text] [Related]

  • 27. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG.
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [Abstract] [Full Text] [Related]

  • 28. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
    Duru F, Fisgin T, Yarali N, Kara A.
    Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
    [Abstract] [Full Text] [Related]

  • 29. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
    Celik M, Bulbul A, Aydogan G, Tugcu D, Can E, Uslu S, Dursun M.
    J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
    [Abstract] [Full Text] [Related]

  • 30. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F.
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [Abstract] [Full Text] [Related]

  • 31. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
    Yildiz I, Ozdemir N, Celkan T, Soylu S, Karaman S, Canbolat A, Dogru O, Erginoz E, Apak H.
    Pediatr Hematol Oncol; 2015 Feb; 32(6):406-14. PubMed ID: 26154620
    [Abstract] [Full Text] [Related]

  • 32. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial.
    Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A.
    Pediatr Blood Cancer; 2009 Jul; 53(1):72-7. PubMed ID: 19301380
    [Abstract] [Full Text] [Related]

  • 33. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
    Dickerhoff R, von Ruecker A.
    J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T.
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [Abstract] [Full Text] [Related]

  • 35. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ.
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA, Evdokimova NM, Rastorguev GG, Samoĭlova OS, Sorokina IV, Sidnev GV, Vasil'ev DM, Anastasiev VV, Milovidova OV, Molodovskaia EV, Borovkov NN.
    Ter Arkh; 1999 Jan; 71(8):50-4. PubMed ID: 10515038
    [Abstract] [Full Text] [Related]

  • 37. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 38. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia.
    Van Riet FA, Wessels G, Hesseling PB.
    East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508
    [Abstract] [Full Text] [Related]

  • 39. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
    O'Brien SH, Ritchey AK, Smith KJ.
    Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
    [Abstract] [Full Text] [Related]

  • 40. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD, Francischetti MM.
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 59.